Clinical Trials Sponsored by Hanben Enterprise

Total 851 results

Chang Gung Memorial Hospital
Hanben Enterprise

Unknown

The Effect of Nutrition for the Colorectal Cancer Patients Receiving Chemotherapy-randomized Controlled Study

Colorectal Cancer

Taiwan
Enterprise Therapeutics Ltd

Completed

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Cystic Fibrosis

United Kingdom
Enterprise Therapeutics Ltd

Completed

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Healthy

United Kingdom
Ceek Enterprises

Completed

Evaluation of the Nella Women's Care Line

GYN Disorders

United States
Universal Enterprises

Unknown

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

Human Volunteers

Pakistan
HealthCare Global Enterprise Ltd.

Unknown

A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients (TEP)

Laryngeal Cancer | Hypopharynx Cancer

India
Richever Enterprise Co., Ltd.

Unknown

Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®)

Galactose Single Point (GSP), Residual Liver Function
Anova Enterprises, Inc

Recruiting

AnovaOS Network Powered Patient Registry

Neoplasms | Infectious Disease | External Causes of Morbidity and Mortality | Pregnancy, Childbirth and the Puerperium | Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | Endocrine, Nutritional and Metabolic Diseases (E00-E89) | Mental... and other conditions

United States
Lander Enterprises, LLC

Completed

Plaque and Gingivitis Evaluation of a U-Shaped Toothbrush in a 30-Day Model

Plaque Induced Gingivitis

United States
NTK Enterprises, Inc.

Terminated

Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System

Hyperopia

United States
Piramal Enterprises Limited

Completed

A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Radiation Induced Mucositis in Head and Neck Cancer

India
Piramal Enterprises Limited

Completed

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Terminated

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

Healthy, Overweight and/or Obese Subjects

India
Piramal Enterprises Limited

Terminated

Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain

Acute Dental Pain
Piramal Enterprises Limited

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

India
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer (SAVIOR)

Pancreatic Cancer

India
Piramal Enterprises Limited

Completed

Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

Canada, India
Innovation Hub Enterprises

Not yet recruiting

COPD Remote Patient Monitoring Through Connected Devices

Chronic Obstructive Pulmonary Disease

United States
Piramal Enterprises Limited

Suspended

Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Suspended

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Terminated

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin

Breast Cancer

United States
Piramal Enterprises Limited

Terminated

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer (SPARK)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Completed

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (Serenity)

Solid Tumor | Hematologic Malignancy

India
HealthCare Global Enterprise Ltd.

Unknown

Role of Imaging to Predict the Deep Surgical Margin in Gingivobuccal Complex Tumors

Buccal Mucosa Cancer | Gingival Cancer

India
HealthCare Global Enterprise Ltd.

Unknown

Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

Squamous Cell Carcinoma | Tongue Neoplasms | Anterior Tongue Squamous Cell Carcinoma

India
Lander Enterprises, LLC

Completed

Plaque Removal Efficacy of a U-Shaped Sonic Power Toothbrush in Children

Dental Plaque

United States
Medical Enterprises Ltd.

Terminated

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. (RITE-USA)

Urinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder Cancer

United States
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Piramal Enterprises Limited

Completed

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

Plaque Psoriasis

India
Piramal Enterprises Limited

Completed

A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies

Cancer

Canada
Piramal Enterprises Limited

Terminated

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, India
Piramal Enterprises Limited

Withdrawn

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

Multiple Myeloma
Piramal Enterprises Limited

Terminated

Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

India
Red Nucleus Enterprise Solutions, LLC

Recruiting

NSAA NON-Interventional Study Protocol

Duchenne Muscular Dystrophy

United States
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy (CLEAR)

Lung Neoplasms

United States
Chen Yi Enterprise, Co., Ltd.

Completed

Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea

Dysmenorrhea

Taiwan
Baio Enterprises
Baio Institute

Active, not recruiting

Neuro Strengths-Based Approach to Autism (NSBAA)

Autism Spectrum Disorder

United States
Medical Enterprises Europe B.V.

Withdrawn

SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (SHTC-EUROPE-1)

Neoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms
FFF Enterprises
OMRIX Biopharmaceuticals

Completed

A Clinical Study of Intravenous Immunoglobulin (IGIV)

Immunologic Deficiency Syndromes

United States, Canada
Medical Enterprises Europe B.V.

Withdrawn

RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

Bladder Cancer
Pharmanex
Nu Skin Enterprises

Completed

Effects of a Nutritional Supplement Combination on Body Weight Management

Safety/Effacy

United States
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

Advanced Solid Tumors

United States
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-small-Cell Lung

Korea, Republic of, Spain, United States, Germany
University College Dublin
Enterprise Ireland

Completed

The Role of Milk Derived Peptides on Glycaemic Control

Insulin Resistance

Ireland
Respivert Ltd
Babraham Institute Enterprise Limited

Completed

Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers

Asthma | COPD

United Kingdom
Hiroshima University
NewBio Enterprise Co., ltd.

Completed

Effect of the Extract of the Flour Fermented With Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose

Prediabetes

Japan
Medical Enterprises Europe B.V.

Terminated

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Neoplasms | Urologic Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Urinary Bladder Cancer | Malignant Tumor of Urinary Bladder

Austria, Israel, Italy, Netherlands
Stanford University
Nu Skin Enterprises

Completed

Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women

Skin Diseases

United States
University of Limerick
Marigot Ltd.; Enterprise Ireland

Completed

The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise

Exercise | Dietary Supplements | Metabolism

Ireland

3

Subscribe